A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
NCT01749891
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
ALG 1001
Sponsor
Allegro Ophthalmics, LLC